Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.
Messenger RNA (mRNA) and microRNA (miRNA)-based therapeutics have become attractive alternatives to DNA-based therapeutics due to recent advances in manufacture, scalability and cost. Also, RNA-based therapeutics are considered safe since there are no risk of inducing genomic changes as well as the...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0224072 |
id |
doaj-a8eb9abbd1d84e8cbb45421a6e121374 |
---|---|
record_format |
Article |
spelling |
doaj-a8eb9abbd1d84e8cbb45421a6e1213742021-03-03T21:15:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011410e022407210.1371/journal.pone.0224072Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.Leena YlösmäkiBeatrice PoliniSara CarpiBeatriz MartinsElena SmertinaSara FeolaManlio FuscielloKarita PeltonenPaola NieriErkko YlösmäkiVincenzo CerulloMessenger RNA (mRNA) and microRNA (miRNA)-based therapeutics have become attractive alternatives to DNA-based therapeutics due to recent advances in manufacture, scalability and cost. Also, RNA-based therapeutics are considered safe since there are no risk of inducing genomic changes as well as the potential adverse effects would be only temporary due to the transient nature of RNA-based therapeutics. However, efficient in vivo delivery of RNA-based therapeutics remains a challenge. We have developed a delivery platform for RNA-based therapeutics by exploiting the physicochemical properties of enveloped viruses. By physically attaching cationic liposome/RNA complexes onto the viral envelope of vaccinia virus, we were able to deliver mRNA, self-replicating RNA as well as miRNA inside target cells. Also, we showed that this platform, called viRNA platform, can efficiently deliver functional miRNA mimics into B16.OVA tumour in vivo.https://doi.org/10.1371/journal.pone.0224072 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Leena Ylösmäki Beatrice Polini Sara Carpi Beatriz Martins Elena Smertina Sara Feola Manlio Fusciello Karita Peltonen Paola Nieri Erkko Ylösmäki Vincenzo Cerullo |
spellingShingle |
Leena Ylösmäki Beatrice Polini Sara Carpi Beatriz Martins Elena Smertina Sara Feola Manlio Fusciello Karita Peltonen Paola Nieri Erkko Ylösmäki Vincenzo Cerullo Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy. PLoS ONE |
author_facet |
Leena Ylösmäki Beatrice Polini Sara Carpi Beatriz Martins Elena Smertina Sara Feola Manlio Fusciello Karita Peltonen Paola Nieri Erkko Ylösmäki Vincenzo Cerullo |
author_sort |
Leena Ylösmäki |
title |
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy. |
title_short |
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy. |
title_full |
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy. |
title_fullStr |
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy. |
title_full_unstemmed |
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy. |
title_sort |
harnessing therapeutic viruses as a delivery vehicle for rna-based therapy. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2019-01-01 |
description |
Messenger RNA (mRNA) and microRNA (miRNA)-based therapeutics have become attractive alternatives to DNA-based therapeutics due to recent advances in manufacture, scalability and cost. Also, RNA-based therapeutics are considered safe since there are no risk of inducing genomic changes as well as the potential adverse effects would be only temporary due to the transient nature of RNA-based therapeutics. However, efficient in vivo delivery of RNA-based therapeutics remains a challenge. We have developed a delivery platform for RNA-based therapeutics by exploiting the physicochemical properties of enveloped viruses. By physically attaching cationic liposome/RNA complexes onto the viral envelope of vaccinia virus, we were able to deliver mRNA, self-replicating RNA as well as miRNA inside target cells. Also, we showed that this platform, called viRNA platform, can efficiently deliver functional miRNA mimics into B16.OVA tumour in vivo. |
url |
https://doi.org/10.1371/journal.pone.0224072 |
work_keys_str_mv |
AT leenaylosmaki harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy AT beatricepolini harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy AT saracarpi harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy AT beatrizmartins harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy AT elenasmertina harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy AT sarafeola harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy AT manliofusciello harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy AT karitapeltonen harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy AT paolanieri harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy AT erkkoylosmaki harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy AT vincenzocerullo harnessingtherapeuticvirusesasadeliveryvehicleforrnabasedtherapy |
_version_ |
1714817856532643840 |